People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,415.50GBp
12:07pm EDT
Price Change (% chg)

3.50p (+0.25%)
Prev Close
1,412.00p
Open
1,412.50p
Day's High
1,425.50p
Day's Low
1,402.50p
Volume
10,137,866
Avg. Vol
9,657,763
52-wk High
1,709.00p
52-wk Low
1,296.50p

Search Stocks

Witty, Andrew 

Brief Biography

Sir Andrew Philip Witty is Chief Executive Officer, Executive Director of GlaxoSmithKline PLC. He joined GSK in 1985. He joined GSK in 1985. He has worked in the UK, South Africa, the USA and Singapore in various senior roles. In 2003, he was appointed President of GSK Europe and joined GSK’s Corporate Executive Team. In 2003 he was awarded the Public Service Medal by the Government of Singapore and in August 2012 was also awarded the Public Service Star. In the 2012 New Year Honours list, he was awarded a Knighthood for services to the economy and to the UK pharmaceutical industry. He served as the Lead Non-Executive Board member for the Department of Business, Innovation and Skills to December 2013. He was also President of the European Federation of Pharmaceutical Industries and Associations until July 2013. Sir Andrew is a member of the UK Prime Minister’s Business Advisory Group and was appointed to the UK Business Ambassador Group in January 2014.

Basic Compensation

Total Annual Compensation, GBP Long-Term Incentive Plans, GBP All Other, GBP Fiscal Year Total, GBP
3,001,000 3,499,000 707,000 7,207,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Christopher Gent

734,000

Andrew Witty

7,207,000

Simon Dingemans

3,292,000

Moncef Slaoui

8,414,000

Deirdre Connelly

--

Roger Connor

--
As Of 30 Dec 2013
Search Stocks